| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/2003 | CN1116044C Antisticking particle and powder containing sodium hyaluronate and their preparation process |
| 07/30/2003 | CN1116043C Process for preparation of coated azithromycin micropill |
| 07/30/2003 | CN1116042C Coposition containing chlopidogrel and antithrombotic agent active component |
| 07/30/2003 | CN1116041C Hernia treating medicine |
| 07/30/2003 | CN1116040C Medicinal composition and its antalgic purpose |
| 07/30/2003 | CN1116039C Molecular dispersion composition with enhanced bioavailability |
| 07/30/2003 | CN1116038C External medicine for treating acne |
| 07/30/2003 | CN1116037C Use of flupirtin for prevention and treatment of disease which are associated with damage to haemopoietic cell system |
| 07/30/2003 | CN1116036C Medicinal composition containing dihydroaremisine for treating rosacea and photosensitive diseases |
| 07/30/2003 | CN1116035C Brain nourishing coposition |
| 07/30/2003 | CN1116034C Acyl urea compounds for treatment of coccidioidomycosis in warmblooded animals |
| 07/30/2003 | CN1116033C Effervescent tablets for curing vaginities and its preparing method |
| 07/30/2003 | CN1116032C Tincture for curing skin diseases |
| 07/30/2003 | CN1116031C Emulsified inhalational anaesthetic for intravenous injection and its preparation |
| 07/30/2003 | CN1116029C Tablet allowing prolonged release of sodium salt of tianeptine after administration by oral |
| 07/30/2003 | CN1115965C Natural plant disinfectant and its preparation |
| 07/30/2003 | CA2369711A1 Macrocyclic peptides active against the hepatitis c virus |
| 07/29/2003 | WO2004065614A2 Suppression of cytotoxic protein conformers |
| 07/29/2003 | US6600073 Sertraline hydrochloride Form III may be produced by heating sertraline hydrochloride Forms V and VI. Sertraline hydrochloride Forms V and VI may be produced from either sertraline hydrochloride or sertraline base by |
| 07/29/2003 | US6600072 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them |
| 07/29/2003 | US6600069 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example |
| 07/29/2003 | US6600063 Novel antimycobacterial compounds and in particular to antimycobacterial compounds comprised of derivatives of phenyl 4-aminosalicylate. This invention further relates to methods for their preparation, to form drugs |
| 07/29/2003 | US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting |
| 07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 07/29/2003 | US6600057 Matrix metalloproteinase inhibitors |
| 07/29/2003 | US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents. |
| 07/29/2003 | US6600047 Substantially free from amlodipine aspartate side products, by reacting amlodipine or an acid addition salt thereof with excess maleic acid under acidic environment |
| 07/29/2003 | US6600045 This invention relates to methods for preparing certain cholesteryl ester transfer protein (CETP) inhibitors and intermediates useful in the preparation of said CETP inhibitors. |
| 07/29/2003 | US6600043 Carboxylic acid derivatives, their preparation and use |
| 07/29/2003 | US6600039 Using potassium-t-butylate in tetrahydrofuran. it is not easy to carry out the process under industrial conditions, yield is low, the product is contaminated, its purification requires repeated crystallization. that by stirring in dimethyl |
| 07/29/2003 | US6600038 Carbamoyl tetrahydropyridine derivatives |
| 07/29/2003 | US6600037 4,5-disubstituted-2-aminopyrimidines |
| 07/29/2003 | US6600036 Treating diseases of the central nervous system. |
| 07/29/2003 | US6600035 6-(substituted methylene) penems and intermediates |
| 07/29/2003 | US6600032 Compound for use in the treatment of viral, protozoan and parasitic infections |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6600010 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same |
| 07/29/2003 | US6599945 Methods for treating subjects infected with a herpes virus |
| 07/29/2003 | US6599944 Ophtalmic compound with extended dwell time on the eye |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599941 Insecticide and insect repellant compositions |
| 07/29/2003 | US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity |
| 07/29/2003 | US6599935 2-phenyl-1,3-propanediol dicarbamate derivatives used as antiepileptic and antiischemic agents |
| 07/29/2003 | US6599934 3,4-diaryl thiopenes and analogs thereof having use as antiinflammatory agents |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599930 Coniosetin and derivatives thereof, process for the preparation and the use thereof |
| 07/29/2003 | US6599929 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/29/2003 | US6599928 Administering agent that inhibits the contraction or migration of smooth muscle cells; sustained dosage; biological stents |
| 07/29/2003 | US6599927 Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome |
| 07/29/2003 | US6599926 Anticoagulant agents for treatment and prevention of thromboembolic disorders |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599923 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 07/29/2003 | US6599919 Administering reversible competitive inhibitor of enzyme in an amount effective to enhance activity of enzyme in cell |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599917 A squalene-synthesizing enzyme inhibitor, a cholesterol biosynthesis inhibitor and a triglyceride biosynthesis inhibitor |
| 07/29/2003 | US6599914 Inhibition of cytokine generation |
| 07/29/2003 | US6599913 Treating allergic and inflammatory conditions |
| 07/29/2003 | US6599912 Methods and compositions for modulating cell proliferation and cell death |
| 07/29/2003 | US6599911 Arylsulfonic acid salts of pyrimidine-based antiviral agents |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599908 Fused polycyclic 2-aminopyrimidine derivatives |
| 07/29/2003 | US6599907 Type V cyclic nucleotide phosphodiesterase inhibitor |
| 07/29/2003 | US6599906 Administering to dental pulp or a trigeminal nerve region of the mammal a first injection of a composition comprising a local anesthetic; and a compound that binds to an SS1 or SS2 subunit of a sodium channel, such as tetrodotoxin |
| 07/29/2003 | US6599905 Pyrazine compounds |
| 07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 07/29/2003 | US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/29/2003 | US6599901 Pyridone substituted benzothiazole derivatives |
| 07/29/2003 | US6599900 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones |
| 07/29/2003 | US6599897 Quetiapine granules |
| 07/29/2003 | US6599896 Use of tianeptine in the production of medicaments to treat neurodegenerative pathologies |
| 07/29/2003 | US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants |
| 07/29/2003 | US6599893 Such as (7R)-7-(2-(2-amino-5-chlorothiazol-4-yl)-2-trityl-oxyiminoacetylamino)-3-(4 -methyl-(1,2, 3)thiadiazol-5-ylsulfanyl)-8-oxo-5-thia-1-aza-bicyclo(4.2.0)oct-2-ene-2 -carboxylic acid benzhydryl ester; methicillin-resistance |
| 07/29/2003 | US6599892 Beta-lactamase inhitiors |
| 07/29/2003 | US6599891 Administering to the subject an amount of a photosensitizer (PS) sufficient to allow said photosensitizer to localize in lesion; irradiating said lesion with light having a wavelength absorbed by said PS |
| 07/29/2003 | US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor |
| 07/29/2003 | US6599888 These combinations have shown a synergistic effect compared with compositions containing either glucosamine alone, or chondroitin sulfate alone |
| 07/29/2003 | US6599886 Macrolide intermediates in the preparation of clarithromycin |
| 07/29/2003 | US6599885 Adduct of antibiotic and mucolytic agent |
| 07/29/2003 | US6599884 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
| 07/29/2003 | US6599883 Nasal delivery of xylitol |
| 07/29/2003 | US6599881 Treating a thrombotic disorder that is not the result of an endotoxin-initiated coagulation cascade in a subject comprising administration of a bactericidal/ permeability-increasing protein (BPI) protein |
| 07/29/2003 | US6599742 Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599627 Microencapsulation of drugs by solvent exchange |
| 07/29/2003 | US6599540 Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer |
| 07/29/2003 | US6599536 Therapy of estrogen-associated disorders |
| 07/29/2003 | US6599535 Bioavailability of drug substance, are convenient to administer, and are stable |
| 07/29/2003 | US6599532 Controlled release alprazolam in the core optionally in combination with an anti-psychotic agent, in a rapid release external coat; smaller, easier to swallow |
| 07/29/2003 | US6599531 Granulating non-steroidal anti-inflammatory agent, colloidal silicon dioxide, disintegrant, binder and starch to form granules; blending with extra-granular material comprised of colloidal silica, disintegrant, filler and starch; compression |
| 07/29/2003 | US6599530 Oral compacted composition comprising catechol derivatives |
| 07/29/2003 | US6599529 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs) |
| 07/29/2003 | US6599527 Preparation of pharmaceutical compositions |
| 07/29/2003 | US6599522 For therapy and prophylaxis of hyperlipidemia (hypertriglyceridemia) |
| 07/29/2003 | US6599521 Absorbent articles for the inhibition of exoprotein production from Gram positive bacteria |
| 07/29/2003 | US6599519 Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 07/29/2003 | US6599511 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence |